stockrowAmylyx Pharmaceuticals, Inc. (AMLX) vs Hims & Hers Health, Inc. (HIMS)
- Amylyx Pharmaceuticals, Inc. AMLX 27.79 −5.48%
- Hims & Hers Health, Inc. HIMS 24.11 −9.56%
Amylyx Pharmaceuticals, Inc. and Hims & Hers Health, Inc. are both Drug Manufacturers Specialty & Generic companies. Hims & Hers Health, Inc. is the larger, with a market value of $5.6B against $3.5B — 1.6× the size. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against −77.1%. Amylyx Pharmaceuticals, Inc. has the higher net margin (0.00% vs −5.51%) and the higher return on invested capital (0.00% vs −11.4%). Across the 17 metrics below, Hims & Hers Health, Inc. leads on 9 and Amylyx Pharmaceuticals, Inc. on 8.
Valuation
Profitability
| Metric | AMLX | HIMS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | (42.65%) | 68.43% | 53.51% |
| Operating margin | 0.00% | (5.99%) | 0.00% |
| Net margin | 0.00% | (5.51%) | (2.45%) |
| Free cash flow margin | 0.00% | 3.22% | 0.00% |
| Return on equity | (74.73%) | (32.03%) | (0.80%) |
| Return on assets | (66.25%) | (5.16%) | (1.67%) |
| Return on invested capital | 0.00% | (11.38%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack